|
|
|
|
pmid:2353317
|
|
|
|
|
pmid:8901008
|
|
|
|
|
pmid:
|
Eyal S et al. |
Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. |
2005 |
Biochem. Pharmacol. |
pmid:15857614
|
Nau H and Loscher W |
Valproic acid and active unsaturated metabolite (2-en): transfer to mouse liver following human therapeutic doses. |
|
Biopharm Drug Dispos |
pmid:3921077
|
Nau H and Zierer R |
Pharmacokinetics of valproic acid and metabolites in mouse plasma and brain following constant-rate application of the drug and its unsaturated metabolite with an osmotic delivery system. |
|
Biopharm Drug Dispos |
pmid:6819013
|
Lücke A et al. |
Diffusion analysis of valproate and trans-2-en-valproate in agar and in cerebral cortex of the rat. |
1993 |
Brain Res. |
pmid:8131047
|
Kassahun K et al. |
Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. |
1994 |
Chem. Biol. Interact. |
pmid:8168173
|
Silva MF et al. |
Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids. |
2001 |
Chem. Biol. Interact. |
pmid:11566289
|
Wong H et al. |
Ontogeny of valproic acid disposition and metabolism: a developmental study in postnatal lambs and adult sheep. |
2000 |
Drug Metab. Dispos. |
pmid:10901700
|